Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
NCT01855490
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
Exenatide
Sponsor
Yale University